Santa Cruz Biotechnology

D2DR (B-10) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; D2DR Antibody (B-10) is an IgG2a κ mouse monoclonal D2DR antibody (also designated DRD2 antibody, or dopamine receptor D2 antibody) that detects the D2DR protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. D2DR Antibody (B-10) is available as both the non-conjugated anti-D2DR antibody form, as well as multiple conjugated forms of anti-D2DR antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The members of the G protein coupled receptor family are distinguished by their slow transmitting response to ligand binding. These transmembrane proteins include the adrenergic, serotonin and dopamine receptors. The effect of the signaling molecule can be excitatory or inhibitory depending on the type of receptor to which it binds. β-adrenergic receptor binds to adrenaline activates adenylyl cyclase, while α2-adrenergic receptor binds to adrenaline inhibits adenylyl cyclase. The dopamine receptors are divided into two classes, D1 and D2, which differ in their functional characteristics in that D1 receptors stimulate adenylyl cyclase while D2 receptors inhibit adenylyl cyclase activity. Five different subtypes of dopamine receptor have been described to date. D1DR and D5DR belong to the D1 subclass, while D2DR, D3DR and D4DR belong to the D2 subclass of dopamine receptors.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.